1607796610 Patent Office Procedure 2

Embed Size (px)

Citation preview

  • 8/2/2019 1607796610 Patent Office Procedure 2

    1/40

    1

    PATENT OFFICEPROCEDURES

    By

    Dr. Gopakumar G. Nair

    Advisor to Pharmexcil, India

    Gopakumar Nair Associates

    Url: www.gnaipr.net

    Email: [email protected]

    Bengaluru, 18th November, 2010

    http://www.gnaipr.net/mailto:[email protected]:[email protected]://www.gnaipr.net/
  • 8/2/2019 1607796610 Patent Office Procedure 2

    2/40

    2

  • 8/2/2019 1607796610 Patent Office Procedure 2

    3/40

    3

    Filing of Patent Application

    When to file :- Earliest as provisional(First-to-File)

    Could continue working & file complete specificationlater

    Provisional Specification

    - To establish PRIORITY DATE / establish earlyownership

    - To pre-empt others

    Complete Specification

    - To be filed within 12 months of filing of Provisional

    Application

  • 8/2/2019 1607796610 Patent Office Procedure 2

    4/40

    4

    Complete Specification

    Title

    Technical Field

    Background and Prior Art

    Current Problem / Drawback / Gap

    Solution to the problem/ Improvement Summary of Invention

    Detailed Description

    Experiments/Trials/Examples

    (incld. Tabular column, if any) Claims

    Abstract

    Drawings

    http://1627-mum-2005-form%202%28granted%29-%2813-11-2009%29.pdf/http://1627-mum-2005-form%202%28granted%29-%2813-11-2009%29.pdf/
  • 8/2/2019 1607796610 Patent Office Procedure 2

    5/40

    5

    Patent Specification - Techno-legal doc

    Unity Of Invention - Single Inventive

    Concept Clarity of Disclosure - State Clearly

    And Distinctly The NatureAnd Limits Of The Claims

    Sufficiency Of Disclosure - Claimsshould be supported byWritten Description.

    Biological Material - GeographicalOrigin

    Pre / Post Grant Opposition & Revocation

  • 8/2/2019 1607796610 Patent Office Procedure 2

    6/40

    6

    Product claims

    Process claims

    Composition claims

    Method of treatment

    New physical forms with

    enhanced efficacy .

    Living organisms .

    (except microorganisms)

    Patent Claims In India

  • 8/2/2019 1607796610 Patent Office Procedure 2

    7/40

    7

    Receiving Office - Delhi, Kolkata, Chennai,Mumbai.

    Language of Filing - English or Hindi

    Forms (2nd Schedule)

    1 (Application for Grant of Patent),

    2 (Complete or Provisional Appln),3 (Statement & Undertaking u/s 8 ),5 (Declaration As to Inventorship) &26 (Power of Attorney)

    Fees (1st Schedule)

    Ratio of Fees 1 : 4 (Natural Person : Others)

    http://form%201.pdf/http://form%202.pdf/http://form%203.pdf/http://form%205.pdf/http://form%2026.pdf/http://form%2026.pdf/http://forms%20%26%20fees.pdf/http://forms%20%26%20fees.pdf/http://form%2026.pdf/http://form%2026.pdf/http://form%2026.pdf/http://form%205.pdf/http://form%205.pdf/http://form%205.pdf/http://form%205.pdf/http://form%203.pdf/http://form%203.pdf/http://form%203.pdf/http://form%202.pdf/http://form%202.pdf/http://form%202.pdf/http://form%202.pdf/http://form%201.pdf/http://form%201.pdf/
  • 8/2/2019 1607796610 Patent Office Procedure 2

    8/40

    8

    Prosecution of a Patent

    1) Optional-Early PublicationOR

    18 months publication (automatic)

    2) Request for Examination

    3) First Examination Report Inventors contribution

    4) Responses to & fro

    5) Acceptance for Grant OR Rejection

    6) Patent Term 20yrs from date of filing.

    http://early%20publication.pdf/http://18%20months%20publication.pdf/http://form%2018.pdf/http://form%2018.pdf/http://18%20months%20publication.pdf/http://early%20publication.pdf/
  • 8/2/2019 1607796610 Patent Office Procedure 2

    9/40

    9

    Fees

    Ratio of Fees 1 : 4 (Natural Person : Others)

    A few examples :Natural Othersperson

    Patent Application- Form 1 & 2 Rs.1000 Rs.4000

    Request for early publication Rs.2500 Rs.10000

    (optional)

    Request for Examination Rs.2500 Rs.10000Maintenance Fee3rd to 6th years Rs.500 Rs.20007th to 10th years Rs.1500 Rs.600011th to 15th years Rs.3000 Rs.1200016th to 20th years Rs.5000 Rs.20000

    http://procedure%20of%20grant%20of%20patent.pdf/
  • 8/2/2019 1607796610 Patent Office Procedure 2

    10/40

    10

    http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/
  • 8/2/2019 1607796610 Patent Office Procedure 2

    11/40

    11

    Types Of Patent

    Provisional Application

    Complete Application

    Convention Application

    Application for Patent of Addition (CIP)

    Cognate Application

    Divisional Application

    PCT International Application

    PCT National Phase Application

    http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://procedure%20of%20grant%20of%20patent.pdf/http://divisional%20application.pdf/http://wo2010092597.pdf/http://national%20phase.pdf/http://national%20phase.pdf/http://national%20phase.pdf/http://national%20phase.pdf/http://wo2010092597.pdf/http://wo2010092597.pdf/http://wo2010092597.pdf/http://divisional%20application.pdf/
  • 8/2/2019 1607796610 Patent Office Procedure 2

    12/40

    12

    Patent Filing Strategies

    Only National Filing

    Only Convention filing (US / EU etc.)

    National + Convention Country

    National + US + EU

    Only PCT

    National + PCT

    Any or all 142 States

    Any or all 142 States

    Patents RIGHTS ARE TERRITORIAL

    (With permission)

    (With permission)

  • 8/2/2019 1607796610 Patent Office Procedure 2

    13/40

    13

    CLAIMDRAFTING

  • 8/2/2019 1607796610 Patent Office Procedure 2

    14/40

    14

    Where To Begin

    Meeting with inventors

    Technical Draft & Experimental Results

    orThesis / Dissertation

  • 8/2/2019 1607796610 Patent Office Procedure 2

    15/40

    15

    What next

    Preliminary Search

    Ask for more info

    Distinguish from Prior Art

    No distinctive featuresN[N/NO-IS/IA]

    Return draft

    Explain how to proceed

    NOVEL/INVENTIVE

    Start drafting

  • 8/2/2019 1607796610 Patent Office Procedure 2

    16/40

    16

    How to Proceed

    Explain elements of patentability

    Novelty/Non-obviousness (inventive step)

    What is not patentableHow to make invention on hand

    patentable

    Create new results/dataRepeat step

  • 8/2/2019 1607796610 Patent Office Procedure 2

    17/40

    17

    Start DraftingRead Technical matter with Prior Art.

    Find key features of invention.

    Process/Product/new use/new application.

    What constitutes the invention ?

    What are the gaps/drawbacks in prior art ?

    What problem is being solved ?

    Start noting down the elements/keywords

    (search once again) (and again)Proceed with drafting

    (Ask more questions; seek more data)

    Proceed

  • 8/2/2019 1607796610 Patent Office Procedure 2

    18/40

    18

    Field of Invention

    Briefly describes the area of technology in whichthe invention falls.

    Often not more then one or two sentences.

    Useful in classification of patent.

    Often starts This invention relates to--

    Ex. This invention relates to pharmaceuticaltablet formulations of clopidogrel

  • 8/2/2019 1607796610 Patent Office Procedure 2

    19/40

    19

    Background

    This section involves Discussion onprogression of technology.

    Description of prior art i.e. the present state

    of technology (state-of-art)Discussion on existing problems in prior

    art.

    Possible solutions offered by presentinvention.

  • 8/2/2019 1607796610 Patent Office Procedure 2

    20/40

    20

    Summary of Invention

    Discloses a gist of present invention.

    Highlights problems solved by presentinvention.

    Reflects the broadest claim.

  • 8/2/2019 1607796610 Patent Office Procedure 2

    21/40

    21

    Brief Description of Drawings

    Drawings are provided for betterunderstanding of invention.

    This section helps to identify the labelsand figures disclosed indrawings.

  • 8/2/2019 1607796610 Patent Office Procedure 2

    22/40

    22

    Detailed Description ofInvention

    Starts with general overview of invention.

    Narrows down to details of theory and all the

    processes and methods for making andusing the invention.

    Invention described with help of preferredembodiments (Best Mode).

    Alternative embodiments can be disclosed.

  • 8/2/2019 1607796610 Patent Office Procedure 2

    23/40

    23

    Claims

    Describe the essential elements and legalboundaries of an invention.

    Should be supported in entirety bySpecification.

    First claim or Independent claim is often thebroadest.

    comprising ofpreferred term.

    -------characterised in that-to distinguishDependent claims expand, qualify, limit,

    narrow, quantify the elements inClaim 1.

  • 8/2/2019 1607796610 Patent Office Procedure 2

    24/40

    24

    Element of a Claim

    1) Preamble Ex :-

    (1)A process for preparation of (comprising)

    (2) An anticancer oral dosage composition(comprising)

    2) Transitional Phrases including, consisting, using,employing, containing, composed of, constituted of.

    Preferred Phrase comprising

    Limiting or Restrictive Phrase characterized inthat

    3) Body or claim elements.

  • 8/2/2019 1607796610 Patent Office Procedure 2

    25/40

    25

    Basic Types of Claims

    Independent Claim.

    Dependent Claims.

    Omnibus Claim

  • 8/2/2019 1607796610 Patent Office Procedure 2

    26/40

    26

    Independent Claim

    Is the first claim.Stands alone.

    Often the broadest claim.

    Broadly describes the invention therebypreventing competitors tocircumvent the invention.

    Prior Art and inventiveness determines

    broadness of the Claim 1.

  • 8/2/2019 1607796610 Patent Office Procedure 2

    27/40

    27

    Dependent Claims

    Depend on first claim.Refer to important distinguishing features

    of the invention as described in

    Claim 1.Claims often narrow-down the scope of

    invention.

    Subject to Unity of Invention, more thanone Independent Claim possible.

    Claims must not be independent

    sentences.

  • 8/2/2019 1607796610 Patent Office Procedure 2

    28/40

    28

    Relationships

    Title (key element in brief) is related to /similar to Claim 1

    1) Abstract (differs only in language)2) Technical field (this invention relates

    to..)

    3) Summary (expanded claim 1 +combined with key elements ofother important claims)

  • 8/2/2019 1607796610 Patent Office Procedure 2

    29/40

    29

    Care & Caution

    Language

    Choice of Tense

    Proof reading

  • 8/2/2019 1607796610 Patent Office Procedure 2

    30/40

    30

    Claim Drafting

    Derive/Determine Keywords/SearchDistinguish Old from New

    Prior Art Novelty

    FOCUS INVENTION FEATURES

    Property/Product/Process

    Structure/Steps/Techniques/Concepts

    use of comprising, and/or, wherein

    separating Preamble from Body

    Independent Claim

    Dependent Claim

  • 8/2/2019 1607796610 Patent Office Procedure 2

    31/40

    31

    Claim Drafting

    INVERTED PYRAMID- Broad to Narrow- Generic to Specific

    Broad Claim (Claim 1)

    Narrow Claim

    Generic

    Specific

  • 8/2/2019 1607796610 Patent Office Procedure 2

    32/40

    32

    Examples Of InnovationOf Inventions

    - Pencil

    - Ink pen

    - Ink-filled pen

    - Ball pen with cap

    - push, expose and write- click and withdraw

    - turn on cap

  • 8/2/2019 1607796610 Patent Office Procedure 2

    33/40

    33

    Claim Drafting

    Caution

    - Claim should not read on

    (overlap) Prior Art

    - Preferably not infringe

  • 8/2/2019 1607796610 Patent Office Procedure 2

    34/40

    34

    Claim Drafting

    Merits/Demerits Benefits/Disadvantages of Broad vs.Narrow Claims.

    Opportunity for broad claim.

    PencilA writing implement comprising:

    a structure causing a mark to be made on a surface, wherein said structure causes said mark on said surface

    upon physical contact with said surface, wherein saidstructure companies a writing material which makes saidmark on said surface upon physical contact with saidsurface, and wherein said writing material comprises asolid material.

  • 8/2/2019 1607796610 Patent Office Procedure 2

    35/40

    35

    Patent Office Requirements

    Size, etc., of documents (1) All documents and copies of

    documents, except affidavits and drawings, sent to or leftat the patent office or otherwise furnished to theController shall be written or typewritten or printed eitherin Hindi or in English language (unless otherwise directedor allowed by the Controller) in large and legiblecharacters with deep indelible ink with lines widely spacedupon one side only of strong white paper of a size A-4 ofapproximately 29.7 centimeters by 21 centimeters with amargin of at least 4 centimeters on the top and left hand

    part and part and 3 cm on the bottom and right hand partthereof. Any signature which is not eligible or which is written in a script other than Hindi or English shall beaccompanied by a transcription of the name either inHindi or in English in block letters:

  • 8/2/2019 1607796610 Patent Office Procedure 2

    36/40

    36

    Patent Office Requirements..contd

    Provided that any document including drawing, if any, mayalso be filed in electronic form alongwith a copy of it onwhite paper:

    Provided further that in case the application for patentdiscloses sequence listing of nucleotides and/or amino acids,the same shall be filed in electronic form.

    (2) Additional copies of all documents shall be filed at the

    appropriate office, if required by the Controller.(3) Names and addresses of applicants and other personsshall be given in full together with their nationality and suchother particulars, if any, as are necessary for identification.

  • 8/2/2019 1607796610 Patent Office Procedure 2

    37/40

    37

    Enablement Requirements

    Section 10 of Indian Patent Act, 1970

    Section 112 Para. 6 of 35 USC

    Written Description

    Deposit and declaration of source forMicroorganism

  • 8/2/2019 1607796610 Patent Office Procedure 2

    38/40

    38

    Examples of Claim 11. A process for measuring the potency of a test batch of glatiramer acetate

    relative to the known potency of a reference batch which comprises:

    a. incubating at least five reference samples, each of which contains apredetermined number of cells from the primary culture such as hereindescribed and a predetermined amount of glatiramer acetate between 1 g/mland 25 g/ml from a reference batch;

    b. incubating at least two samples, each of which contains a predeterminednumber of cells from the primary culture such as herein described & apredetermined amount of glatiramer acetate from the test batch;

    c. determining for each sample in steps (a) and (b), the amount of cytokinesecreted by the cells in each sample after a predetermined time period ofincubation of such sample;

    d. correlating the amounts of cytokine secreted by the samples incubatedwith the test batch of glatiramer acetate with the amounts of cytokine such asherein describe secreted by the samples incubated with the reference batch of

    glatiramer acetate so as to determine the potency of the test batch ofglatiramer acetate relative to the reference batch of the glatiramer acetate, wherein in each sample in steps (a) and (b), the predetermined number ofcells is substantially identical, and wherein for each sample containing apredetermined amount of glatiramer acetate from the test batch there is acorresponding reference sample containing a substantially identicalpredetermined amount of glatiramer acetate from the reference batch.

  • 8/2/2019 1607796610 Patent Office Procedure 2

    39/40

    39

    Examples of Claim 1

    Claim 1. A pharmaceutical composition comprising:(a) activated botulinum toxin type B; and (b) at least oneexcipient; wherein at least 90% of said botulinum toxin type B isnicked.

    Claim 1. Biscuit comprising guar gum characterized in that saidguar gum is a native guar gum, with a length between 0.25 and 8mm, a width between 0.18 and 2mm and an average length towidth ratio between 1.8 and 6.

    Claim 1. A facet-joint exercise device for massaging tissue around a

    spinal column of a user, said facet-joint exercise devicecharacterized by: a pair of spheres mounted in a frame, theframe having a mounting yoke; a track for mounting the frame toa vertical support surface; and a means for adjustably securingthe frame to the track; wherein the spheres are mounted on ashaft in the frame, so as to be freely rotatable about the shaft,

    and wherein the frame is height adjustable on the frame.

  • 8/2/2019 1607796610 Patent Office Procedure 2

    40/40

    Examples of Claim 1

    Claim 1. A device for testing a heat sensitivity in teeth comprising: a base; and

    a tip having a cushion, wherein the cushion comprises a heating element,and wherein the cushion conforms to a contour of a tooth tested for a heatsensitivity.

    Claim 1. A method for treating fibrosis in a mammal which comprisesadministering to the mammal a cell which expresses and secretes the Flt3ligand in an effective amount to treat fibrosis.

    Claim 1. A method of extracting cardiac glycosides, comprising: intermixing acardiac glycoside plant species with aloe under conditions selected to forman extraction mixture; conditioning the extraction mixture underconditions selected to extract cardiac glycosides from said cardiacglycoside plant species to thereby form a conditioned extraction mixture,

    wherein the conditioned extraction mixture comprises residua] cardiac

    glycoside plant species and a cardiac glycoside aloe mixture; separating atleast a portion of the cardiac glycoside aloe mixture from the residualcardiac glycoside plant species to thereby form a cardiac glycoside aloeextract, wherein the cardiac glycoside aloe extract comprises cardiacglycosides extracted from said cardiac glycoside plant species; and whereinsaid cardiac glycoside aloe extract is substantially free of the residualcardiac glycoside plant species.